logo-loader
RNS
viewValiRx PLC

ValiRx PLC - General Meeting - Adjournment

RNS Number : 5351H
ValiRx PLC
25 March 2020
 

ValiRx Plc

("ValiRx" or the "Company")

 

GENERAL MEETING - Adjournment

 

London, UK. 25 March 2020: ValiRx Plc (AIM: VAL), a clinical stage biotechnology company, provides an update on its Notice of General Meeting ("GM"), which was due to be held today at 11:00.

 

Due to the current COVID-19 situation, the meeting has been adjourned until further notice.

 

A further announcement will be made in due course.

 

For more information, please contact:

 

ValiRx plc

Tel: +44 (0) 20 7073 2628

www.valirx.com

Dr Satu Vainikka, Chief Executive

Tel: +44 (0) 20 7073 2628

Tarquin Edwards, Head of Communications.

Tel: +44 (0) 7879 458 364

[email protected]

 

Cairn Financial Advisers LLP - Nominated Adviser

 


Liam Murray / Jo Turner

 

Tel: +44 (0) 20 7213 0880



 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCEANDSALAEEEA

Quick facts: ValiRx PLC

Price: 6.75

Market: AIM
Market Cap: £2.43 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

ValiRx Plc enjoying strong industry interest in its cancer treatments

George Morris, chief operations officer at ValiRx Plc (LON:VAL), updates Proactive's Andrew Scott on developments across the company's portfolio. Morris says advanced conversations are continuing with possible partners as they look to press ahead with the development of their flagship...

on 19/7/18